Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia

Metabolism: Clinical and Experimental

Volumn 59, Issue 2, 2010, Pages 293-298

  Real, Jose T ^a,b   Martínez Hervás, Sergio ^a,b   Tormos, M Carmen ^c   Domenech, Elena ^c   Pallardó, Federico V ^c,d   Sáez Tormo, Guillermo ^c   Redon, Josep ^a,e   Carmena, Rafael ^a,b   Chaves, F Javier ^a,b   Ascaso, Juan F ^a,b   García García, Ana Barbara ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^e Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MALE; MONONUCLEAR CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; ANTIOXIDANTS; ATHEROSCLEROSIS; CATALASE; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LEUKOCYTES, MONONUCLEAR; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

EID: 74049163677     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.07.026     Document Type: Article

References (31)

1. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232 (1986) 34-47
2. Ferrières J., Lambert J., Lussier-Cacan S., and Davignon J. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation 92 (1995) 290-295
3. Moorjani S., Roy M., Torres A., Bétard C., Gagné C., Lambert M., et al. Mutations of low density lipoprotein receptor gene variation in plasma cholesterol and expression of coronary heart disease in homozygous familial hypercholesterolemia. Lancet 341 (1993) 1303-1306
4. Real J.T., Chaves F.J., Martínez-Usó I., García-García A.B., Ascaso J.F., and Carmena R. Importance of HDL cholesterol levels and total to HDL cholesterol ratio as risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolemia. Eur Heart J 22 (2001) 465-471
5. Paoletti R., Gotto A.M., and Hajjar D.P. Inflammation in atherosclerosis and implications for therapy. Circulation 109 (2004) 20-26
6. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., and Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106 (2002) 927-932
7. Papaharalambus C.A., and Griendling K.K. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 17 (2007) 48-54
8. Heistad D.D. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler Thromb Vasc Biol 26 (2006) 689-695
9. Spiekermann S., Landmesser U., Dikalov S., Bredt M., Gamez G., Tatge H., et al. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 107 (2003) 1383-1389
10. Stephens J.W., Gable D.R., Hurel S.J., Miller G.J., Cooper J.A., and Humphries S.E. Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clin Chem 52 (2006) 446-452
11. Martínez-Hervás S., Fandos M., Real J.T., Espinosa O., Chaves F.J., Saez G.T., et al. Insulin resistance and oxidative stress in familial combined hyperlipidemia. Atherosclerosis 199 (2008) 384-389
12. Chaves F.J., Mansego M.L., Blesa S., Gonzalez-Albert V., Jiménez J., Tormos M.C., et al. Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens 20 (2007) 62-69
13. Redón J., Oliva M.R., Tormos C., Giner V., Chaves F.J., Iradi A., et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41 (2003) 1096-1101
14. Chaves F.J., Corella D., Blesa S., Mansego M.L., Marín P., Portoles O., et al. Xanthine oxidoreductase polymorphisms: influence in blood pressure and oxidative stress levels. Pharmacogenet Genomics 17 (2007) 589-596
15. Nourooz-Zadeh J., Smith C.C., and Betteridge D.J. Measures of oxidative stress in heterozygous familial hypercholesterolemia. Atherosclerosis 156 (2001) 435-441
16. Matthews D.R., hosker J.P., Rudenski A.S., Naylor B.A., Teacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and b cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28 (1985) 412-419
17. Chaves F.J., Real J.T., García-García A.B., Civera M., Armengod M.E., Ascaso J.F., et al. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total LDL and high density lipoprotein cholesterol. J Clin Endocrin Metab 86 (2001) 4926-4932
18. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
19. Ter Welle H.F., Baartscheer T., and Fiolet J.W.T. Influence of free glycerol on enzymatic evaluation of triglycerides. Clin Chem 30 (1984) 1102-1103
20. Burstein M., Scholnick H.R., and Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11 (1970) 583-595
21. Rosseneu M., Vercaemst R., Steinberg K.K., and Cooper G.R. Some considerations of methodology and standardization of apolipoprotein B immunoassays. Clin Chem 29 (1983) 427-433
22. Oltra A.M., Carbonell F., Tormos C., Iradi A., and Sáez G.T. Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia. Free Radic Biol Med 30 (2001) 1286-1292
23. Navarro J., Obrador E., Pellicer J.A., Asensi M., Viña J., and Estrela J.M. Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. Free Radic Biol Med 22 (1997) 1203-1209
24. Nebot C., Moutet M., Huet P., Xu J.Z., Yadan J.C., and Chaudiere J. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 214 (1993) 442-451
25. Aebi H. Catalase in vitro. Methods Enzymol 105 (1984) 121-126
26. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-169
27. Miller A.A., De Silva T.M., Jackman K.A., and Sobey C.G. Effect of gender and sex hormones on vascular oxidative stress. Clin Exp Pharmacol Physiol 34 (2007) 1037-1043
28. Martino F., Pignatelli P., Martino E., Morrone F., Carnevale R., Di Santo S., et al. Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia. J Am Coll Cardiol 49 (2007) 1974-1981
29. Gomez-Cabrera M.C., Martínez A., Santangelo G., Pallardó F.V., Sastre J., and Viña J. Oxidative stress in marathon runners: interest of antioxidant supplementation. Br J Nutr 96 (2006) S31-S33
30. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., and Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 52 (2006) 601-623
31. Blankenberg S., Rupprecht H.J., Bickel C., Torzewski M., Hafner G., Tiret L., et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349 (2003) 1595-1604